A real-world pharmacovigilance study of romidepsin based on FDA adverse event reporting system database.
Saved in:
| Title: | A real-world pharmacovigilance study of romidepsin based on FDA adverse event reporting system database. |
|---|---|
| Authors: | Yang Y; Department of Pharmacy, The Second People's Hospital, Wuhu, Anhui, China., Huang Y; Department of Pharmacy, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, Fuzhou, Fujian, China., Wang Y; College of Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, China., Chen Y; Department of Pharmacy, Pingtan Comprehensive Experimental Area Hospital, Pingtan Comprehensive Experimental Area, Fuzhou, China., Ke C; Department of Pharmacy, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, China.; Department of Pharmacy, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China., Chen M; Department of Pharmacy, Pingtan Comprehensive Experimental Area Hospital, Pingtan Comprehensive Experimental Area, Fuzhou, China. |
| Source: | Frontiers in oncology [Front Oncol] 2026 Jun 10; Vol. 16, pp. 1694602. Date of Electronic Publication: 2026 Jun 10 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2234-943X |
|---|---|
| DOI: | 10.3389/fonc.2026.1694602 |